D
Utah Medical Products, Inc.
UTMD
$58.33
-$0.33-0.56%
D
Sell
11/4/2024Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 11/4/2024 due to a large decline in the growth index, volatility index and solvency index. Operating cash flow declined 47.65% from $5.28M to $2.76M, EBIT declined 12.11% from $4.63M to $4.07M, and earnings per share declined from $1.09 to $0.9778.
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 11/4/2024 due to a large decline in the growth index, volatility index and solvency index. Operating cash flow declined 47.65% from $5.28M to $2.76M, EBIT declined 12.11% from $4.63M to $4.07M, and earnings per share declined from $1.09 to $0.9778.
C
Hold
8/1/2024Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to C- from D+ on 8/1/2024 due to an increase in the volatility index and total return index.
Utah Medical Products, Inc. (UTMD) was upgraded to C- from D+ on 8/1/2024 due to an increase in the volatility index and total return index.
D
Sell
7/17/2024Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 7/17/2024 due to a decline in the valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 7/17/2024 due to a decline in the valuation index and dividend index.
C
Hold
7/2/2024Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to C- from D+ on 7/2/2024 due to an increase in the valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was upgraded to C- from D+ on 7/2/2024 due to an increase in the valuation index and dividend index.
D
Sell
6/17/2024Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 6/17/2024 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 17.31% from $5.6M to $4.63M, total revenue declined 8.05% from $12.33M to $11.34M, and earnings per share declined from $1.18 to $1.09.
Utah Medical Products, Inc. (UTMD) was downgraded to D+ from C- on 6/17/2024 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 17.31% from $5.6M to $4.63M, total revenue declined 8.05% from $12.33M to $11.34M, and earnings per share declined from $1.18 to $1.09.
C
Hold
2/13/2024Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C- from C on 2/13/2024 due to a noticeable decline in the total return index, volatility index and efficiency index.
Utah Medical Products, Inc. (UTMD) was downgraded to C- from C on 2/13/2024 due to a noticeable decline in the total return index, volatility index and efficiency index.
C
Hold
10/27/2023Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 10/27/2023 due to a decline in the volatility index, total return index and growth index. EBIT declined 15.64% from $4.71M to $3.97M, earnings per share declined from $1.154 to $1.081, and total revenue declined 2.81% from $12.87M to $12.51M.
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 10/27/2023 due to a decline in the volatility index, total return index and growth index. EBIT declined 15.64% from $4.71M to $3.97M, earnings per share declined from $1.154 to $1.081, and total revenue declined 2.81% from $12.87M to $12.51M.
C
Hold
9/15/2023Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 9/15/2023 due to a decline in the volatility index and total return index.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 9/15/2023 due to a decline in the volatility index and total return index.
B
Buy
8/31/2023Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 8/31/2023 due to an increase in the valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 8/31/2023 due to an increase in the valuation index and dividend index.
C
Hold
4/17/2023Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from B on 4/17/2023 due to a decline in the valuation index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from B on 4/17/2023 due to a decline in the valuation index.
B
Buy
4/12/2023Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B from C on 4/12/2023 due to a large increase in the volatility index, growth index and efficiency index. EBIT increased 11.65% from $5.14M to $5.74M, net income increased 6.43% from $4.28M to $4.56M, and earnings per share increased from $1.178 to $1.2532.
Utah Medical Products, Inc. (UTMD) was upgraded to B from C on 4/12/2023 due to a large increase in the volatility index, growth index and efficiency index. EBIT increased 11.65% from $5.14M to $5.74M, net income increased 6.43% from $4.28M to $4.56M, and earnings per share increased from $1.178 to $1.2532.
C
Hold
4/26/2022Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 4/26/2022 due to a noticeable decline in the volatility index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 4/26/2022 due to a noticeable decline in the volatility index.
C
Hold
3/25/2022Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 3/25/2022 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 16.76% from $5.99M to $4.99M, and earnings per share declined from $1.15 to $1.1258.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 3/25/2022 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 16.76% from $5.99M to $4.99M, and earnings per share declined from $1.15 to $1.1258.
B
Buy
2/17/2022Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 2/17/2022 due to a decline in the total return index, valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 2/17/2022 due to a decline in the total return index, valuation index and dividend index.
B
Buy
1/26/2022Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 1/26/2022 due to an increase in the valuation index, volatility index and dividend index.
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 1/26/2022 due to an increase in the valuation index, volatility index and dividend index.
B
Buy
12/7/2021Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 12/7/2021 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 27.69% from $4.69M to $5.99M, earnings per share increased from $0.937 to $1.15, and EBIT increased 6.99% from $4.77M to $5.1M.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 12/7/2021 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 27.69% from $4.69M to $5.99M, earnings per share increased from $0.937 to $1.15, and EBIT increased 6.99% from $4.77M to $5.1M.
C
Hold
10/19/2021Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 10/19/2021 due to a decline in the total return index, valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 10/19/2021 due to a decline in the total return index, valuation index and dividend index.
C
Hold
9/20/2021Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to C+ from C on 9/20/2021 due to a large increase in the growth index, valuation index and volatility index. EBIT increased 22.56% from $3.89M to $4.77M, total revenue increased 14.96% from $10.96M to $12.6M, and earnings per share increased from $0.827 to $0.937.
Utah Medical Products, Inc. (UTMD) was upgraded to C+ from C on 9/20/2021 due to a large increase in the growth index, valuation index and volatility index. EBIT increased 22.56% from $3.89M to $4.77M, total revenue increased 14.96% from $10.96M to $12.6M, and earnings per share increased from $0.827 to $0.937.
C
Hold
3/26/2021Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 3/26/2021 due to a decline in the valuation index, volatility index and total return index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 3/26/2021 due to a decline in the valuation index, volatility index and total return index.
C
Hold
3/11/2021Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to C+ from C on 3/11/2021 due to an increase in the volatility index, total return index and efficiency index.
Utah Medical Products, Inc. (UTMD) was upgraded to C+ from C on 3/11/2021 due to an increase in the volatility index, total return index and efficiency index.
C
Hold
11/10/2020Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to C from C- on 11/10/2020 due to a major increase in the growth index, valuation index and volatility index. Earnings per share increased from $0.359 to $0.803, EBIT increased 81.44% from $1.98M to $3.59M, and operating cash flow increased 36.2% from $3.68M to $5.01M.
Utah Medical Products, Inc. (UTMD) was upgraded to C from C- on 11/10/2020 due to a major increase in the growth index, valuation index and volatility index. Earnings per share increased from $0.359 to $0.803, EBIT increased 81.44% from $1.98M to $3.59M, and operating cash flow increased 36.2% from $3.68M to $5.01M.
C
Hold
11/9/2020Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C- from C on 11/9/2020 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $0.843 to $0.359, EBIT declined 48.82% from $3.86M to $1.98M, and operating cash flow declined 35.2% from $5.67M to $3.68M.
Utah Medical Products, Inc. (UTMD) was downgraded to C- from C on 11/9/2020 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $0.843 to $0.359, EBIT declined 48.82% from $3.86M to $1.98M, and operating cash flow declined 35.2% from $5.67M to $3.68M.
C
Hold
5/1/2020Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 5/1/2020 due to a noticeable decline in the volatility index and total return index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from C+ on 5/1/2020 due to a noticeable decline in the volatility index and total return index.
C
Hold
4/17/2020Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 4/17/2020 due to a decline in the volatility index, total return index and efficiency index.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 4/17/2020 due to a decline in the volatility index, total return index and efficiency index.
B
Buy
3/2/2020Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 03/02/2020.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C on 03/02/2020.
C
Hold
2/11/2020Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C from B- on 2/11/2020 due to a noticeable decline in the total return index, efficiency index and growth index.
Utah Medical Products, Inc. (UTMD) was downgraded to C from B- on 2/11/2020 due to a noticeable decline in the total return index, efficiency index and growth index.
B
Buy
11/27/2019Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 11/27/2019 due to a decline in the total return index and volatility index.
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 11/27/2019 due to a decline in the total return index and volatility index.
B
Buy
11/12/2019Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 11/12/2019 due to a substantial increase in the growth index, total return index and efficiency index. Operating cash flow increased 278.61% from $1.68M to $6.37M, total revenue increased 5.47% from $11.85M to $12.49M, and net income increased 5.11% from $3.53M to $3.71M.
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 11/12/2019 due to a substantial increase in the growth index, total return index and efficiency index. Operating cash flow increased 278.61% from $1.68M to $6.37M, total revenue increased 5.47% from $11.85M to $12.49M, and net income increased 5.11% from $3.53M to $3.71M.
B
Buy
10/3/2019Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 10/3/2019 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 5.33 to 9.98.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 10/3/2019 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 5.33 to 9.98.
C
Hold
5/1/2019Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 5/1/2019 due to a decline in the volatility index, growth index and efficiency index. Net income declined 49.82% from $6.76M to $3.39M, earnings per share declined from $1.802 to $0.9051, and total revenue declined 6.1% from $10.39M to $9.76M.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 5/1/2019 due to a decline in the volatility index, growth index and efficiency index. Net income declined 49.82% from $6.76M to $3.39M, earnings per share declined from $1.802 to $0.9051, and total revenue declined 6.1% from $10.39M to $9.76M.
B
Buy
11/14/2018Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 11/14/2018 due to a major increase in the growth index, valuation index and efficiency index. Earnings per share increased from $1.148 to $1.802, net income increased 56.96% from $4.31M to $6.76M, and operating cash flow increased 15.65% from $3.98M to $4.6M.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 11/14/2018 due to a major increase in the growth index, valuation index and efficiency index. Earnings per share increased from $1.148 to $1.802, net income increased 56.96% from $4.31M to $6.76M, and operating cash flow increased 15.65% from $3.98M to $4.6M.
C
Hold
9/11/2018Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 9/11/2018 due to a large decline in the total return index, volatility index and growth index.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 9/11/2018 due to a large decline in the total return index, volatility index and growth index.
B
Buy
7/24/2018Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 7/24/2018 due to a large decline in the total return index.
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B on 7/24/2018 due to a large decline in the total return index.
B
Buy
6/20/2018Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 6/20/2018 due to a noticeable increase in the volatility index and total return index.
Utah Medical Products, Inc. (UTMD) was upgraded to B from B- on 6/20/2018 due to a noticeable increase in the volatility index and total return index.
B
Buy
5/11/2018Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 5/11/2018 due to a substantial increase in the growth index, solvency index and efficiency index. Net income increased 262.25% from -$2.52M to $4.09M, earnings per share increased from -$0.674 to $1.092, and the quick ratio increased from 8.25 to 9.21.
Utah Medical Products, Inc. (UTMD) was upgraded to B- from C+ on 5/11/2018 due to a substantial increase in the growth index, solvency index and efficiency index. Net income increased 262.25% from -$2.52M to $4.09M, earnings per share increased from -$0.674 to $1.092, and the quick ratio increased from 8.25 to 9.21.
C
Hold
4/13/2018Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 4/13/2018 due to a decline in the valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was downgraded to C+ from B- on 4/13/2018 due to a decline in the valuation index and dividend index.
B
Buy
3/12/2018Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B+ on 3/12/2018 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 169.63% from $3.62M to -$2.52M, earnings per share declined from $0.969 to -$0.674, and total capital declined 3.79% from $81.2M to $78.12M.
Utah Medical Products, Inc. (UTMD) was downgraded to B- from B+ on 3/12/2018 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 169.63% from $3.62M to -$2.52M, earnings per share declined from $0.969 to -$0.674, and total capital declined 3.79% from $81.2M to $78.12M.
B
Buy
2/20/2018Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 2/20/2018 due to an increase in the total return index, volatility index and solvency index.
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 2/20/2018 due to an increase in the total return index, volatility index and solvency index.
B
Buy
10/5/2017Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B from B+ on 10/5/2017 due to a decline in the volatility index, valuation index and dividend index.
Utah Medical Products, Inc. (UTMD) was downgraded to B from B+ on 10/5/2017 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
8/21/2017Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 8/21/2017 due to an increase in the total return index and volatility index.
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 8/21/2017 due to an increase in the total return index and volatility index.
B
Buy
8/4/2017Downgrade
Utah Medical Products, Inc. (UTMD) was downgraded to B from B+ on 8/4/2017 due to a decline in the growth index, total return index and efficiency index. Operating cash flow declined 20.25% from $4.31M to $3.44M.
Utah Medical Products, Inc. (UTMD) was downgraded to B from B+ on 8/4/2017 due to a decline in the growth index, total return index and efficiency index. Operating cash flow declined 20.25% from $4.31M to $3.44M.
B
Buy
7/20/2017Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 7/20/2017 due to an increase in the total return index and volatility index.
Utah Medical Products, Inc. (UTMD) was upgraded to B+ from B on 7/20/2017 due to an increase in the total return index and volatility index.
B
Buy
7/12/2017Upgraded
Utah Medical Products, Inc. (UTMD) was upgraded to B from C on 7/12/2017 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from $0.7242 to $0.948, EBIT increased 28.57% from $3.68M to $4.73M, and operating cash flow increased 25.86% from $3.42M to $4.31M.
Utah Medical Products, Inc. (UTMD) was upgraded to B from C on 7/12/2017 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from $0.7242 to $0.948, EBIT increased 28.57% from $3.68M to $4.73M, and operating cash flow increased 25.86% from $3.42M to $4.31M.
C
Hold
8/24/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to C from B on 8/24/2016 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 12.99% from $4.13M to $3.6M.
Utah Medical Products Inc. (UTMD) was downgraded to C from B on 8/24/2016 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 12.99% from $4.13M to $3.6M.
B
Buy
6/30/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 6/30/2016 due to a decline in the volatility index.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 6/30/2016 due to a decline in the volatility index.
B
Buy
6/15/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 6/15/2016 due to a decline in the total return index.
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 6/15/2016 due to a decline in the total return index.
A
Buy
5/31/2016Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A- from B on 5/31/2016 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 12.12% from $3.85M to $4.31M, total revenue increased 8.31% from $9.51M to $10.3M, and operating cash flow increased 5.81% from $3.91M to $4.13M.
Utah Medical Products Inc. (UTMD) was upgraded to A- from B on 5/31/2016 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 12.12% from $3.85M to $4.31M, total revenue increased 8.31% from $9.51M to $10.3M, and operating cash flow increased 5.81% from $3.91M to $4.13M.
B
Buy
3/11/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 3/11/2016 due to a major decline in the volatility index and growth index. Operating cash flow declined 6.15% from $4.16M to $3.91M, EBIT declined 3.85% from $4M to $3.85M, and total revenue declined 3.65% from $9.87M to $9.51M.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 3/11/2016 due to a major decline in the volatility index and growth index. Operating cash flow declined 6.15% from $4.16M to $3.91M, EBIT declined 3.85% from $4M to $3.85M, and total revenue declined 3.65% from $9.87M to $9.51M.
B
Buy
2/29/2016Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 2/29/2016 due to an increase in the volatility index and total return index.
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 2/29/2016 due to an increase in the volatility index and total return index.
B
Buy
2/11/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 2/11/2016 due to a decline in the total return index.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 2/11/2016 due to a decline in the total return index.
B
Buy
1/27/2016Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 1/27/2016 due to an increase in the volatility index and valuation index.
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 1/27/2016 due to an increase in the volatility index and valuation index.
B
Buy
1/12/2016Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 1/12/2016 due to a decline in the volatility index, total return index and valuation index.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 1/12/2016 due to a decline in the volatility index, total return index and valuation index.
B
Buy
12/28/2015Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 12/28/2015 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 4.66 to 4.73.
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 12/28/2015 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 4.66 to 4.73.
B
Buy
8/10/2015Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 8/10/2015 due to a decline in the volatility index, dividend index and efficiency index.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 8/10/2015 due to a decline in the volatility index, dividend index and efficiency index.
B
Buy
7/30/2015Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 7/30/2015 due to an increase in the volatility index, valuation index and dividend index.
Utah Medical Products Inc. (UTMD) was upgraded to B+ from B on 7/30/2015 due to an increase in the volatility index, valuation index and dividend index.
B
Buy
7/15/2015Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 7/15/2015 due to a decline in the volatility index.
Utah Medical Products Inc. (UTMD) was downgraded to B from B+ on 7/15/2015 due to a decline in the volatility index.
B
Buy
7/13/2015Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 7/13/2015 due to a decline in the volatility index, valuation index and dividend index.
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 7/13/2015 due to a decline in the volatility index, valuation index and dividend index.
A
Buy
6/12/2015Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 6/12/2015 due to an increase in the volatility index.
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 6/12/2015 due to an increase in the volatility index.
B
Buy
5/28/2015Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 5/28/2015 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 50.47% from $4.53M to $2.24M, EBIT declined 11.38% from $4.38M to $3.88M, and earnings per share declined from $0.7955 to $0.706.
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 5/28/2015 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 50.47% from $4.53M to $2.24M, EBIT declined 11.38% from $4.38M to $3.88M, and earnings per share declined from $0.7955 to $0.706.
A
Buy
3/4/2015Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 3/4/2015 due to a decline in the valuation index.
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 3/4/2015 due to a decline in the valuation index.
A
Buy
1/5/2015Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 1/5/2015 due to a noticeable increase in the volatility index and total return index.
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 1/5/2015 due to a noticeable increase in the volatility index and total return index.
A
Buy
12/1/2014Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 12/1/2014 due to an increase in the volatility index and total return index.
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 12/1/2014 due to an increase in the volatility index and total return index.
B
Buy
11/7/2014Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 11/7/2014 due to a decline in the growth index, valuation index and total return index. EBIT declined 1.48% from $4.06M to $4M, and earnings per share declined from $0.751 to $0.75.
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 11/7/2014 due to a decline in the growth index, valuation index and total return index. EBIT declined 1.48% from $4.06M to $4M, and earnings per share declined from $0.751 to $0.75.
A
Buy
9/5/2014Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 9/5/2014 due to a large increase in the growth index, solvency index and efficiency index. Operating cash flow increased 99.69% from $1.92M to $3.84M, debt to equity declined from 0.13 to 0.11, and total revenue increased 6.76% from $9.83M to $10.49M.
Utah Medical Products Inc. (UTMD) was upgraded to A- from B+ on 9/5/2014 due to a large increase in the growth index, solvency index and efficiency index. Operating cash flow increased 99.69% from $1.92M to $3.84M, debt to equity declined from 0.13 to 0.11, and total revenue increased 6.76% from $9.83M to $10.49M.
B
Buy
6/2/2014Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 6/2/2014 due to a noticeable decline in the volatility index.
Utah Medical Products Inc. (UTMD) was downgraded to B+ from A- on 6/2/2014 due to a noticeable decline in the volatility index.
A
Buy
5/12/2014Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 5/12/2014 due to a noticeable decline in the volatility index and growth index. Operating cash flow declined 40.88% from $3.25M to $1.92M, earnings per share declined from $0.9165 to $0.719, and total revenue declined 2.56% from $10.09M to $9.83M.
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 5/12/2014 due to a noticeable decline in the volatility index and growth index. Operating cash flow declined 40.88% from $3.25M to $1.92M, earnings per share declined from $0.9165 to $0.719, and total revenue declined 2.56% from $10.09M to $9.83M.
A
Buy
4/15/2014Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 4/15/2014 due to an increase in the valuation index and dividend index.
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 4/15/2014 due to an increase in the valuation index and dividend index.
A
Buy
3/31/2014Downgrade
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 3/31/2014 due to a decline in the valuation index and dividend index.
Utah Medical Products Inc. (UTMD) was downgraded to A- from A on 3/31/2014 due to a decline in the valuation index and dividend index.
A
Buy
3/14/2014Upgraded
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 3/14/2014 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.68 to $0.9165, the quick ratio increased from 2.05 to 2.47, and debt to equity declined from 0.17 to 0.15.
Utah Medical Products Inc. (UTMD) was upgraded to A from A- on 3/14/2014 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.68 to $0.9165, the quick ratio increased from 2.05 to 2.47, and debt to equity declined from 0.17 to 0.15.
NASDAQ
03/06/2025 4:00PM Eastern
Quotes delayed
